Diagnostyka S.A. (WSE:DIA)

Diagnostyka Statistics

Total Valuation

Diagnostyka has a market cap or net worth of PLN 6.14 billion. The enterprise value is 7.13 billion.

Market Cap	6.14B
Enterprise Value	7.13B

Important Dates

The next estimated earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Diagnostyka has 33.76 million shares outstanding.

Current Share Class	33.76M
Shares Outstanding	33.76M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	14.81%
Float	33.75M

Valuation Ratios

The trailing PE ratio is 23.02 and the forward PE ratio is 19.73. Diagnostyka's PEG ratio is 0.62.

PE Ratio	23.02
Forward PE	19.73
PS Ratio	2.67
PB Ratio	11.99
P/TBV Ratio	n/a
P/FCF Ratio	17.22
P/OCF Ratio	11.85
PEG Ratio	0.62

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.64, with an EV/FCF ratio of 19.98.

EV / Earnings	26.71
EV / Sales	3.10
EV / EBITDA	12.64
EV / EBIT	19.12
EV / FCF	19.98

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.96.

Current Ratio	0.73
Quick Ratio	0.62
Debt / Equity	1.96
Debt / EBITDA	1.78
Debt / FCF	2.82
Interest Coverage	5.72

Financial Efficiency

Return on equity (ROE) is 60.79% and return on invested capital (ROIC) is 21.48%.

Return on Equity (ROE)	60.79%
Return on Assets (ROA)	13.51%
Return on Invested Capital (ROIC)	21.48%
Return on Capital Employed (ROCE)	26.17%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	293,179
Profits Per Employee	34,064
Employee Count	7,836
Asset Turnover	1.33
Inventory Turnover	11.10

Taxes

In the past 12 months, Diagnostyka has paid 55.42 million in taxes.

Income Tax	55.42M
Effective Tax Rate	16.68%

Stock Price Statistics

The stock price has increased by +39.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+39.57%
50-Day Moving Average	180.25
200-Day Moving Average	180.88
Relative Strength Index (RSI)	44.59
Average Volume (20 Days)	50,315

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diagnostyka had revenue of PLN 2.30 billion and earned 266.93 million in profits. Earnings per share was 7.91.

Revenue	2.30B
Gross Profit	1.77B
Operating Income	372.80M
Pretax Income	332.30M
Net Income	266.93M
EBITDA	454.32M
EBIT	372.80M
Earnings Per Share (EPS)	7.91

Balance Sheet

The company has 37.44 million in cash and 1.01 billion in debt, with a net cash position of -968.08 million or -28.68 per share.

Cash & Cash Equivalents	37.44M
Total Debt	1.01B
Net Cash	-968.08M
Net Cash Per Share	-28.68
Equity (Book Value)	512.26M
Book Value Per Share	14.67
Working Capital	-134.62M

Cash Flow

In the last 12 months, operating cash flow was 518.26 million and capital expenditures -161.49 million, giving a free cash flow of 356.78 million.

Operating Cash Flow	518.26M
Capital Expenditures	-161.49M
Free Cash Flow	356.78M
FCF Per Share	10.57

Margins

Gross margin is 77.09%, with operating and profit margins of 16.23% and 11.62%.

Gross Margin	77.09%
Operating Margin	16.23%
Pretax Margin	14.46%
Profit Margin	11.62%
EBITDA Margin	19.78%
EBIT Margin	16.23%
FCF Margin	15.53%

Dividends & Yields

This stock pays an annual dividend of 3.31, which amounts to a dividend yield of 1.84%.

Dividend Per Share	3.31
Dividend Yield	1.84%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	41.86%
Buyback Yield	n/a
Shareholder Yield	1.84%
Earnings Yield	4.34%
FCF Yield	5.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Diagnostyka has an Altman Z-Score of 4.34 and a Piotroski F-Score of 5.

Altman Z-Score	4.34
Piotroski F-Score	5